News-Medical.Net July 11, 2023
Danielle Ellis, B.Sc.

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

Through joint research with the Korea Institute of Machinery and Materials (President Sang Jin Park, hereinafter referred to as KIMM), the Korea Research Institute of Bioscience and Biotechnology (President Jang Seong Kim, hereinafter referred to as KRIBB), institute under the jurisdiction of the Ministry of Science and ICT, developed a 3D bioprinting technology using natural killer cells (NK cells) as a new method of immunotherapy for treating cancer, and announced the outcome of the research on Biomaterials Research (IF: 11. 3), a renowned journal.

Allowing the 3D-printed hydrogels to encapsulate NK cells helps to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Provider, Technology
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article